Flexibility and Control - A World of New Possibilities
PanTHERA CryoSolutions provides cryoprotectant products for use in a variety of cell and tissue systems. Our patented ice recrystallization inhibitors (IRIs) significantly improve post-thaw recovery and the quality of cell-based therapeutics.
Exceptional Protection
Our products provide exceptional protection against transient warming during both normal storage and distribution. Our IRIs offer beneficial options for alternative shipping methods that allow more flexibility in the supply chain of cryopreserved cells.
Benefits
Significant Cost Reductions
PanTHERA reduces operational including logistics and shipping. In certain applications IRIs allow for higher sub-zero storage of samples reducing the cost of banking cell inventories.
Improved Performance & Opportunities
PanTHERAs IRI’s improve post-thaw recovery and functionality of cells which can positively impact research and patient outcomes.
Applications
- Research and development
- Gene and cell therapy products
- Organ, tissue, and blood banking
- Biomanufacturing industry (such as viral vectors, oncolytic virus, recombinant proteins, vaccines)
- Assisted reproductive technologies
- Animal and aquaculture-specific breeding and preservation
News & Events
BioLife Solutions and PanTHERA CryoSolutions combine strengths via an acquisition that will enable the development of next generation cryopreservation solutions
By Ana Clementin
/ 7 April 2025
EDMONTON, ALBERTA (April 7th, 2025) -- PanTHERA CryoSolutions Inc., (“PanTHERA”) a Canadian company developing innovative products to protect frozen cells,...
Read More
PanTHERA Feature: David Lewandowski, Director of Business Development at AmplifyBio
By Elizabeth Tan
/ 16 July 2024
PanTHERA CryoSolutions had the opportunity to sit down with David Lewandowski, presently Director of Business Development, at AmplifyBio, to chat...
Read More
Scientist Feature: Dr. Esme Dijke, Director at the Histocompatibility Laboratory and Assistant Professor for Lab Medicine and Pathology.
By Elizabeth Tan
/ 29 May 2024
PanTHERA had an incredible opportunity to chat with Dr. Esme Dijke, Director at the Histocompatibility Laboratory and Assistant Professor for...
Read More
Unlocking Quality: Understanding GMP Grade Products
By Elizabeth Tan
/ 14 April 2024
Ensuring the safety and efficacy of pharmaceuticals, biotechnology products, and certain food and dietary supplements is paramount. This commitment to...
Read More
Cryopreservation: A Key to Conserving Biodiversity
By Elizabeth Tan
/ 29 February 2024
In the face of unprecedented environmental changes and human activities, the preservation of biodiversity has become a global imperative. Biodiversity,...
Read More
Scientist Feature: Dr. Anna Jezierski, Research Officer with the Human Health Therapeutics Research Centre at the NRC
By Elizabeth Tan
/ 19 December 2023
PanTHERA CryoSolutions sat down with Dr. Anna Jezierski to hear from her about her work and how our novel Ice...
Read More
Revolutionizing Agriculture: The Crucial Role of Cryopreservation
By Elizabeth Tan
/ 23 November 2023
Revolutionizing Agriculture: The Crucial Role of Cryopreservation In the ever-evolving landscape of agriculture, advancements in technology continue to shape the...
Read More
The Vital Role of Ice Recrystallization Inhibitors in Cold Chain Management
By Elizabeth Tan
/ 23 November 2023
The Vital Role of Ice Recrystallization Inhibitors in Cold Chain Management In the world of logistics and supply chain management,...
Read More
Ice Recrystallization Inhibitors: A Promising Breakthrough in Cryopreservation
By Elizabeth Tan
/ 26 July 2023
Ice Recrystallization Inhibitors: A Promising Breakthrough in Cryopreservation Cryopreservation, the process of preserving biological materials at extremely low temperatures, is...
Read More
PanTHERA CryoSolutions Press Coverage
By Elizabeth Tan
/ 21 July 2023
PanTHERA CryoSolutions is honoured to be featured in various news outlets across the country. These articles are a testament to...
Read More
